Most Read This Week
- Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination–Related Genes
- Efficacy of CTC Count–Driven vs Clinician-Driven First-Line Therapy Choice in HR+, ERBB2− Metastatic Breast Cancer
- Everolimus, Letrozole, and Trastuzumab in Patients With HR+ Metastatic Breast Cancer or Other Solid Tumors
- Locoregional Surgery Improves OS in Patients With De Novo Stage IV Breast Cancer
- Dr. Farzanna Haffizulla: A Very Low Threshold for Bias
Recently Updated
- Three Barriers to Improving Breast Cancer Outcomes in Sub-Saharan Africa
- Equivocal HER2
- Clinical Outcomes of Breast Cancer Patients Treated in Phase I Clinical Trials at the University of Colorado Cancer Center
- Yoga Practice Predicts Improvements in Day-to-Day Pain in Women With MBC
- Immunomodulatory Activity of a CSF-1 Receptor Inhibitor in Patients With Advanced Refractory Breast or Prostate Cancer